Mainz Biomed Expands AI Collaboration With Liquid Biosciences to Include Pancreatic Cancer Test

MT Newswires Live09-04

Mainz Biomed (MYNZ) said Wednesday that it expanded its collaboration with Liquid Biosciences to include PancAlert, Mainz Biomed's detection test for pancreatic cancer.

The company said the expanded collaboration will allow it to leverage Liquid Biosciences' proprietary artificial intelligence analysis technology platform EMERGE to "expand and optimize" novel biomarkers selection for PancAlert.

Mainz Biomed said the collaboration's first phase evaluated biomarkers from its research program and based on the results, the partners determined that a PancAlert diagnostic test could be combined with Mainz Biomed's colorectal cancer screening product in the future.

The partners plan to continue with the second phase of the collaboration, which covers the evaluation of microbiome biomarkers that were analyzed in collaboration with Microba Life Sciences in 2023, according to the statement. This analysis is expected to be completed in Q4, said Mainz Biomed.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2464326297?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-04 17:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2464326297","market":"sh","top_or_hot":-1,"title":"Mainz Biomed Expands AI Collaboration With Liquid Biosciences to Include Pancreatic Cancer Test","media":"MT Newswires Live","content":"<html><body><p> Mainz Biomed (MYNZ) said Wednesday that it expanded its collaboration with Liquid Biosciences to include PancAlert, Mainz Biomed's detection test for pancreatic cancer.</p><p>The company said the expanded collaboration will allow it to leverage Liquid Biosciences' proprietary artificial intelligence analysis technology platform EMERGE to \"expand and optimize\" novel biomarkers selection for PancAlert.</p><p>Mainz Biomed said the collaboration's first phase evaluated biomarkers from its research program and based on the results, the partners determined that a PancAlert diagnostic test could be combined with Mainz Biomed's colorectal cancer screening product in the future.</p><p>The partners plan to continue with the second phase of the collaboration, which covers the evaluation of microbiome biomarkers that were analyzed in collaboration with Microba Life Sciences in 2023, according to the statement. This analysis is expected to be completed in Q4, said Mainz Biomed.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mainz Biomed Expands AI Collaboration With Liquid Biosciences to Include Pancreatic Cancer Test</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMainz Biomed Expands AI Collaboration With Liquid Biosciences to Include Pancreatic Cancer Test\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-04 17:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Mainz Biomed (MYNZ) said Wednesday that it expanded its collaboration with Liquid Biosciences to include PancAlert, Mainz Biomed's detection test for pancreatic cancer.The company said the expanded ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2464326297","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2464326297","pubTimestamp":1725442335,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Mainz Biomed  said Wednesday that it expanded its collaboration with Liquid Biosciences to include PancAlert, Mainz Biomed's detection test for pancreatic cancer.The company said the expanded collaboration will allow it to leverage Liquid Biosciences' proprietary artificial intelligence analysis technology platform EMERGE to \"expand and optimize\" novel biomarkers selection for PancAlert.Mainz Biomed said the collaboration's first phase evaluated biomarkers from its research program and based on the results, the partners determined that a PancAlert diagnostic test could be combined with Mainz Biomed's colorectal cancer screening product in the future.The partners plan to continue with the second phase of the collaboration, which covers the evaluation of microbiome biomarkers that were analyzed in collaboration with Microba Life Sciences in 2023, according to the statement. This analysis is expected to be completed in Q4, said Mainz Biomed.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","MYNZ":"Mainz Biomed B.V."},"translate_title":"Mainz Biomed扩大与Liquid Biosciences的人工智能合作，将胰腺癌测试纳入其中","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MYNZ":1},"content_text":"Mainz Biomed (MYNZ) said Wednesday that it expanded its collaboration with Liquid Biosciences to include PancAlert, Mainz Biomed's detection test for pancreatic cancer.The company said the expanded collaboration will allow it to leverage Liquid Biosciences' proprietary artificial intelligence analysis technology platform EMERGE to \"expand and optimize\" novel biomarkers selection for PancAlert.Mainz Biomed said the collaboration's first phase evaluated biomarkers from its research program and based on the results, the partners determined that a PancAlert diagnostic test could be combined with Mainz Biomed's colorectal cancer screening product in the future.The partners plan to continue with the second phase of the collaboration, which covers the evaluation of microbiome biomarkers that were analyzed in collaboration with Microba Life Sciences in 2023, according to the statement. This analysis is expected to be completed in Q4, said Mainz Biomed.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2464326297"}